Focus: Neurotech Pharmaceuticals specializes in encapsulated cell therapy for neurology, gene therapy, and cell therapy applications, with a focused pipeline centered on the NT-501 implant platform. The company is headquartered in Cumberland, RI with a small active footprint of 7 open positions.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
Stable — net -4 jobs in 30d
4 added, 8 removed. Backfill posture.
Early-stage, capital-dependent biotech with innovative cell therapy focus; suitable only for risk-tolerant candidates committed to pioneering neurology science with uncertain near-term viability.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Neurotech Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Neurotech Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles